TAAR5
gene geneOn this page
Also known as PNR
Summary
TAAR5 (trace amine associated receptor 5, HGNC:30236) is a protein-coding gene on chromosome 6q23.2, encoding Trace amine-associated receptor 5 (O14804). Olfactory receptor specific for trimethylamine, a trace amine.
Enables trimethylamine receptor activity. Involved in adenylate cyclase-activating G protein-coupled receptor signaling pathway. Is active in plasma membrane.
Source: NCBI Gene 9038 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 59 total — 1 pathogenic
- Druggable target: yes
- MANE Select transcript:
NM_003967
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30236 |
| Approved symbol | TAAR5 |
| Name | trace amine associated receptor 5 |
| Location | 6q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PNR |
| Ensembl gene | ENSG00000135569 |
| Ensembl biotype | protein_coding |
| OMIM | 607405 |
| Entrez | 9038 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000258034
RefSeq mRNA: 2 — MANE Select: NM_003967
NM_001389527, NM_003967
CCDS: CCDS5156
Canonical transcript exons
ENST00000258034 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000919228 | 132588592 | 132589741 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 97.76.
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.76 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.91 | gold quality |
| myocardium | UBERON:0002349 | 67.79 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 58.78 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 55.24 | gold quality |
| cartilage tissue | UBERON:0002418 | 53.66 | gold quality |
| sperm | CL:0000019 | 50.66 | gold quality |
| oocyte | CL:0000023 | 48.12 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.94 | gold quality |
| gingiva | UBERON:0001828 | 46.89 | gold quality |
| vastus lateralis | UBERON:0001379 | 46.79 | gold quality |
| gingival epithelium | UBERON:0001949 | 45.88 | gold quality |
| cardia of stomach | UBERON:0001162 | 44.42 | gold quality |
| upper leg skin | UBERON:0004262 | 44.28 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 43.03 | gold quality |
| amniotic fluid | UBERON:0000173 | 42.90 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| trachea | UBERON:0003126 | 42.13 | gold quality |
| ventral tegmental area | UBERON:0002691 | 41.39 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| biceps brachii | UBERON:0001507 | 41.20 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| parotid gland | UBERON:0001831 | 40.76 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| granulocyte | CL:0000094 | 40.48 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 40.41 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- Previous studies reported TAAR expression in brain. This paper found TAAR expression only in olfactory epithelial cells and that each TAAR detects a unique set of amine ligands. TAARs seem to function as a family of chemosensory receptors for amines. (PMID:16878137)
- Human trace amine-associated receptor TAAR5 can be activated by trimethylamine. (PMID:23393561)
- The murine and human TAAR5 (hTAAR5) display significant basal activity in the Gq/11 pathway. (PMID:25706283)
- Sequence Variants in TAAR5 and Other Loci Affect Human Odor Perception and Naming. (PMID:33035477)
- Pattern of TAAR5 Expression in the Human Brain Based on Transcriptome Datasets Analysis. (PMID:34445502)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | taar13d | ENSDARG00000110650 |
| danio_rerio | taar13b | ENSDARG00000112016 |
| danio_rerio | taar13c | ENSDARG00000112794 |
| danio_rerio | taar13a | ENSDARG00000113793 |
| danio_rerio | taar13e | ENSDARG00000115277 |
| mus_musculus | Taar5 | ENSMUSG00000069706 |
| rattus_norvegicus | Taar5 | ENSRNOG00000039869 |
Paralogs (25): DRD4 (ENSG00000069696), HRH3 (ENSG00000101180), HRH2 (ENSG00000113749), CHRM3 (ENSG00000133019), HRH4 (ENSG00000134489), GPR84 (ENSG00000139572), GPR161 (ENSG00000143147), TAAR2 (ENSG00000146378), TAAR6 (ENSG00000146383), TAAR8 (ENSG00000146385), TAAR1 (ENSG00000146399), DRD3 (ENSG00000151577), HTR4 (ENSG00000164270), CHRM1 (ENSG00000168539), DRD5 (ENSG00000169676), HTR1A (ENSG00000178394), HTR1D (ENSG00000179546), CHRM4 (ENSG00000180720), CHRM2 (ENSG00000181072), DRD1 (ENSG00000184845), CHRM5 (ENSG00000184984), GPR21 (ENSG00000188394), HRH1 (ENSG00000196639), GPR52 (ENSG00000203737), TAAR9 (ENSG00000237110)
Protein
Protein identifiers
Trace amine-associated receptor 5 — O14804 (reviewed: O14804)
Alternative names: Putative neurotransmitter receptor
All UniProt accessions (1): O14804
UniProt curated annotations — full annotation on UniProt →
Function. Olfactory receptor specific for trimethylamine, a trace amine. Also activated at lower level by dimethylethylamine. Trimethylamine is a bacterial metabolite found in some animal odors, and to humans it is a repulsive odor associated with bad breath and spoiled food. Trimethylamine-binding causes a conformation change that triggers signaling via G(s)-class of G alpha proteins (GNAL or GNAS).
Subcellular location. Cell membrane.
Tissue specificity. Expressed almost exclusively in skeletal muscle and selected areas of the brain, such amygdala, hippocampus, caudate nucleus, thalamus and hypothalamus. Weak expression is also find in substantia nigra.
Domain organisation. In addition to the well known disulfide bond common to G-protein coupled receptor 1 family, trace amine-associated receptors (TAARs) contain an unique disulfide bond (Cys-24-Cys-188) connecting the N-terminus to the extracellular Loop 2 (ECL2), which is required for agonist-induced receptor activation.
Miscellaneous. Polymorphic variants of this gene are not associated with specific anosmia for trimethylamine.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001376456, NP_003958* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR009132 | TAAR_fam | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050569 | TAAR | Family |
Pfam: PF00001
UniProt features (27 total): topological domain 8, transmembrane region 7, sequence conflict 5, disulfide bond 2, sequence variant 2, chain 1, region of interest 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14804-F1 | 84.94 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 24–188, 99–192
Glycosylation sites (1): 21
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-375280 | Amine ligand-binding receptors |
| R-HSA-418555 | G alpha (s) signalling events |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
MSigDB gene sets: 38 (showing top):
GOBP_COGNITION, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, LHX3_01, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION, GOBP_SENSORY_PERCEPTION, TAATTA_CHX10_01, GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY, REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS, chr6q23, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY
GO Biological Process (6): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189), sensory perception of smell (GO:0007608), cognition (GO:0050890), sensory perception of chemical stimulus (GO:0007606)
GO Molecular Function (3): trace-amine receptor activity (GO:0001594), G protein-coupled receptor activity (GO:0004930), trimethylamine receptor activity (GO:1990081)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| Class A/1 (Rhodopsin-like receptors) | 1 |
| GPCR downstream signalling | 1 |
| Signal Transduction | 1 |
| GPCR ligand binding | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1 |
| adenylate cyclase activator activity | 1 |
| sensory perception of chemical stimulus | 1 |
| nervous system process | 1 |
| sensory perception | 1 |
| G protein-coupled amine receptor activity | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| trace-amine receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
652 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAAR5 | MOXD1 | Q6UVY6 | 905 |
| TAAR5 | STX7 | O15400 | 833 |
| TAAR5 | FMO3 | P31513 | 530 |
| TAAR5 | OR1C1 | Q15619 | 514 |
| TAAR5 | VNN1 | O95497 | 493 |
| TAAR5 | OR1A1 | Q9P1Q5 | 488 |
| TAAR5 | OR52K2 | Q8NGK3 | 482 |
| TAAR5 | OR52A1 | Q9UKL2 | 462 |
| TAAR5 | OR2J3 | O76001 | 456 |
| TAAR5 | CNGA2 | Q16280 | 454 |
| TAAR5 | OR5A2 | Q8NGI9 | 445 |
| TAAR5 | OR5A1 | Q8NGJ0 | 445 |
| TAAR5 | OR2J1 | Q9GZK6 | 438 |
| TAAR5 | OR7D4 | Q8NG98 | 436 |
| TAAR5 | OR52H1 | Q8NGJ2 | 432 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: O02667, O14804, P29275, P29276, Q1LZD0, Q32ZE2, Q5QD04, Q5QD05, Q5QD06, Q5QD07, Q5QD08, Q5QD09, Q5QD10, Q5QD11, Q5QD12, Q5QD13, Q5QD14, Q5QD15, Q5QD16, Q5QD17, Q5QD21, Q5QD23, Q5QD24, Q5QD25, Q5QD28, Q5QD29, Q5QNP2, Q5W8W0, Q60614, Q6W3F4, Q8HZ64, Q923X5, Q923X6, Q923X8, Q923X9, Q923Y0, Q923Y1, Q923Y2, Q923Y3, Q923Y4
Diamond homologs: A0A678XMK4, O02662, O02666, O14804, O19091, O42574, O70528, O77680, O77700, P07700, P11617, P17124, P18089, P21728, P23944, P25021, P25100, P25102, P25115, P28221, P28565, P35405, P35406, P42289, P42290, P42291, P43141, P46626, P47747, P47800, P49145, P50406, P53452, P53454, P60021, P61752, P79400, P97288, P97292, P97714
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 6 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2685213 | GRCh37/hg19 6q22.31-23.3(chr6:120218852-137160850)x1 | Pathogenic |
SpliceAI
218 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:132588754:CCA:C | acceptor_gain | 0.7900 |
| 6:132588755:CAC:C | acceptor_gain | 0.7900 |
| 6:132588757:C:CC | acceptor_gain | 0.7800 |
| 6:132588755:CA:C | acceptor_gain | 0.6900 |
| 6:132588760:G:C | acceptor_gain | 0.6600 |
| 6:132588757:C:T | acceptor_loss | 0.6500 |
| 6:132588760:G:GC | acceptor_gain | 0.6500 |
| 6:132589658:TCAGC:T | donor_gain | 0.6400 |
| 6:132589555:G:A | donor_gain | 0.6100 |
| 6:132589244:A:AC | donor_gain | 0.5900 |
| 6:132589245:C:CC | donor_gain | 0.5900 |
| 6:132588759:G:C | acceptor_loss | 0.5700 |
| 6:132589043:A:C | acceptor_gain | 0.5700 |
| 6:132589533:T:A | donor_gain | 0.5600 |
| 6:132589042:C:CT | acceptor_gain | 0.5400 |
| 6:132589052:C:CT | acceptor_gain | 0.5300 |
| 6:132589625:TTCA:T | donor_loss | 0.5200 |
| 6:132589626:TCA:T | donor_loss | 0.5200 |
| 6:132589627:CACCT:C | donor_loss | 0.5200 |
| 6:132589628:A:AG | donor_loss | 0.5200 |
| 6:132589657:TTCAG:T | donor_gain | 0.5200 |
| 6:132588753:ACCA:A | acceptor_gain | 0.5100 |
| 6:132588754:CCAC:C | acceptor_gain | 0.5100 |
| 6:132589033:CAAG:C | acceptor_gain | 0.5100 |
| 6:132589037:C:CC | acceptor_gain | 0.5100 |
| 6:132588752:AACCA:A | acceptor_gain | 0.5000 |
| 6:132588812:C:CT | acceptor_gain | 0.5000 |
| 6:132589053:A:T | acceptor_gain | 0.5000 |
| 6:132589630:C:G | donor_loss | 0.5000 |
| 6:132589043:A:AC | acceptor_gain | 0.4900 |
AlphaMissense
2201 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:132589292:C:G | R132P | 0.975 |
| 6:132589212:A:G | W159R | 0.968 |
| 6:132589212:A:T | W159R | 0.968 |
| 6:132589501:G:C | F62L | 0.964 |
| 6:132589501:G:T | F62L | 0.964 |
| 6:132589503:A:G | F62L | 0.964 |
| 6:132588751:A:C | F312L | 0.959 |
| 6:132588751:A:T | F312L | 0.959 |
| 6:132588753:A:G | F312L | 0.959 |
| 6:132589367:C:G | C107S | 0.958 |
| 6:132589368:A:T | C107S | 0.958 |
| 6:132589311:A:G | C126R | 0.956 |
| 6:132588883:G:C | F268L | 0.952 |
| 6:132588883:G:T | F268L | 0.952 |
| 6:132588885:A:G | F268L | 0.952 |
| 6:132589447:G:C | D80E | 0.950 |
| 6:132589447:G:T | D80E | 0.950 |
| 6:132589293:G:T | R132S | 0.947 |
| 6:132589387:C:A | W100C | 0.947 |
| 6:132589387:C:G | W100C | 0.947 |
| 6:132588897:A:G | C264R | 0.945 |
| 6:132589448:T:G | D80A | 0.944 |
| 6:132589215:C:G | G158R | 0.942 |
| 6:132589215:C:T | G158R | 0.942 |
| 6:132589448:T:A | D80V | 0.942 |
| 6:132589449:C:G | D80H | 0.940 |
| 6:132589531:A:C | N52K | 0.940 |
| 6:132589531:A:T | N52K | 0.940 |
| 6:132589053:A:G | C212R | 0.939 |
| 6:132588813:A:G | W292R | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1000171485 (6:132593326 C>G,T), RS1000219906 (6:132597187 T>C), RS1000258358 (6:132613280 G>A), RS1000273676 (6:132596902 C>G,T), RS1000311572 (6:132608385 C>T), RS1000363555 (6:132608043 A>T), RS1000426141 (6:132613678 T>G), RS1000621473 (6:132602517 C>T), RS1000858588 (6:132612108 G>A), RS1000859144 (6:132613452 A>G,T), RS1001090681 (6:132604880 G>A,C), RS1001124474 (6:132598079 T>C), RS1001176707 (6:132597752 G>A), RS1001222584 (6:132595915 C>T), RS1001226409 (6:132601179 A>G)
Disease associations
OMIM: gene MIM:607405 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011623_4 | Odorant perception | 6.000000e-15 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3714046 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — TAAR2, TAAR3, TAAR4p, TAAR5, TAAR6, TAAR8, TAAR9
Most potent curated ligand interactions (2 total), top 2:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| trimethylamine | Full agonist | 6.52 | pEC50 |
| dimethylethylamine | Full agonist | 6.15 | pEC50 |
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.36 | EC50 | 4400 | nM | CHEMBL1182312 |
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation, affects methylation | 2 |
| trimethylamine | increases activity | 1 |
| N,N-dimethylethylamine | increases activity | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
ChEMBL screening assays
3 unique, capped per target: 3 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL3788460 | Binding | Inverse agonist activity at human TAAR5 expressed in HEK293 cells by Alphascreen assay | A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists — Medchemcomm |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KZ16 | PathHunter CHO-K1 TAAR5 beta-arrestin | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.